cloudfront

Report Detail



Pharmaceuticals & HealthcareArrhythmias - Pipeline Review, H2 2018

  • RnM2315579
  • |
  • 7 August, 2018
  • |
  • Global
  • |
  • 52 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Arrhythmias - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Arrhythmias - Overview

              Arrhythmias - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Arrhythmias - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Arrhythmias - Companies Involved in Therapeutics Development

                                      Cynata Therapeutics Ltd

                                        Gilead Sciences Inc

                                          LATITUDE Pharmaceuticals Inc

                                            Les Laboratoires Servier SAS

                                              OMEICOS Therapeutics GmbH

                                                Ono Pharmaceutical Co Ltd

                                                  Orion Corporation

                                                    SignPath Pharma Inc

                                                      Arrhythmias - Drug Profiles

                                                        amiodarone - Drug Profile

                                                          Product Description

                                                            Mechanism Of Action

                                                              R&D Progress

                                                                Antisense Oligonucleotides to Activate hERG1 for Arrhythmias - Drug Profile

                                                                  Product Description

                                                                    Mechanism Of Action

                                                                      R&D Progress

                                                                        efsevin - Drug Profile

                                                                          Product Description

                                                                            Mechanism Of Action

                                                                              R&D Progress

                                                                                EU-8120 - Drug Profile

                                                                                  Product Description

                                                                                    Mechanism Of Action

                                                                                      R&D Progress

                                                                                        GS-680 - Drug Profile

                                                                                          Product Description

                                                                                            Mechanism Of Action

                                                                                              R&D Progress

                                                                                                GS-967 - Drug Profile

                                                                                                  Product Description

                                                                                                    Mechanism Of Action

                                                                                                      R&D Progress

                                                                                                        KN-93 - Drug Profile

                                                                                                          Product Description

                                                                                                            Mechanism Of Action

                                                                                                              R&D Progress

                                                                                                                landiolol - Drug Profile

                                                                                                                  Product Description

                                                                                                                    Mechanism Of Action

                                                                                                                      R&D Progress

                                                                                                                        M-201 - Drug Profile

                                                                                                                          Product Description

                                                                                                                            Mechanism Of Action

                                                                                                                              R&D Progress

                                                                                                                                OMT-28 - Drug Profile

                                                                                                                                  Product Description

                                                                                                                                    Mechanism Of Action

                                                                                                                                      R&D Progress

                                                                                                                                        ORM-10103 - Drug Profile

                                                                                                                                          Product Description

                                                                                                                                            Mechanism Of Action

                                                                                                                                              R&D Progress

                                                                                                                                                PAM-4 - Drug Profile

                                                                                                                                                  Product Description

                                                                                                                                                    Mechanism Of Action

                                                                                                                                                      R&D Progress

                                                                                                                                                        PP-1 - Drug Profile

                                                                                                                                                          Product Description

                                                                                                                                                            Mechanism Of Action

                                                                                                                                                              R&D Progress

                                                                                                                                                                Small Molecules to Antagonize RyR2 for Heart Failure and Arrhythmias - Drug Profile

                                                                                                                                                                  Product Description

                                                                                                                                                                    Mechanism Of Action

                                                                                                                                                                      R&D Progress

                                                                                                                                                                        Small Molecules to Target FKBP1A for Cardiovascular Diseases - Drug Profile

                                                                                                                                                                          Product Description

                                                                                                                                                                            Mechanism Of Action

                                                                                                                                                                              R&D Progress

                                                                                                                                                                                SPP-4040 - Drug Profile

                                                                                                                                                                                  Product Description

                                                                                                                                                                                    Mechanism Of Action

                                                                                                                                                                                      R&D Progress

                                                                                                                                                                                        Stem Cell Therapy for Asthma and Cardiovacular Diseases - Drug Profile

                                                                                                                                                                                          Product Description

                                                                                                                                                                                            Mechanism Of Action

                                                                                                                                                                                              R&D Progress

                                                                                                                                                                                                Arrhythmias - Dormant Projects

                                                                                                                                                                                                  Arrhythmias - Discontinued Products

                                                                                                                                                                                                    Arrhythmias - Product Development Milestones

                                                                                                                                                                                                      Featured News & Press Releases

                                                                                                                                                                                                        Sep 27, 2017: U.S. Patent Granted for Cynata Cymerus Technology

                                                                                                                                                                                                          Sep 05, 2017: Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

                                                                                                                                                                                                            Apr 19, 2017: Cynata Advances to Pre-IND Meeting with US FDA

                                                                                                                                                                                                              Appendix

                                                                                                                                                                                                                Methodology

                                                                                                                                                                                                                  Coverage

                                                                                                                                                                                                                    Secondary Research

                                                                                                                                                                                                                      Primary Research

                                                                                                                                                                                                                        Expert Panel Validation

                                                                                                                                                                                                                          Contact Us

                                                                                                                                                                                                                            Disclaimer

                                                                                                                                                                                                                            Arrhythmias - Pipeline Review, H2 2018

                                                                                                                                                                                                                            Summary

                                                                                                                                                                                                                            Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias - Pipeline Review, H2 2018, provides an overview of the Arrhythmias (Cardiovascular) pipeline landscape.

                                                                                                                                                                                                                            An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. Signs and symptoms include anxiety, weakness, dizziness, and light-headedness, fainting or nearly fainting, sweating, shortness of breath and chest pain. Treatment includes anti-arrhythmics and anticoagulants.

                                                                                                                                                                                                                            Report Highlights

                                                                                                                                                                                                                            Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Arrhythmias - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Arrhythmias (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                                                                                                                            The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 1, 9 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

                                                                                                                                                                                                                            Arrhythmias (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                                                                                                                            Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                                                                                                                            Scope

                                                                                                                                                                                                                            - The pipeline guide provides a snapshot of the global therapeutic landscape of Arrhythmias (Cardiovascular).
                                                                                                                                                                                                                            - The pipeline guide reviews pipeline therapeutics for Arrhythmias (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                                                                                                                            - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                                                                                                                            - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                                                                                                                            - The pipeline guide reviews key companies involved in Arrhythmias (Cardiovascular) therapeutics and enlists all their major and minor projects.
                                                                                                                                                                                                                            - The pipeline guide evaluates Arrhythmias (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                                                                                                                            - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                                                                                                                            - The pipeline guide reviews latest news related to pipeline therapeutics for Arrhythmias (Cardiovascular)

                                                                                                                                                                                                                            Reasons to buy

                                                                                                                                                                                                                            - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                                                                                                                            - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                                                                                                                            - Find and recognize significant and varied types of therapeutics under development for Arrhythmias (Cardiovascular).
                                                                                                                                                                                                                            - Classify potential new clients or partners in the target demographic.
                                                                                                                                                                                                                            - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                                                                                                                            - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                                                                                                                            - Formulate corrective measures for pipeline projects by understanding Arrhythmias (Cardiovascular) pipeline depth and focus of Indication therapeutics.
                                                                                                                                                                                                                            - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                                                                                                                            - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.




                                                                                                                                                                                                                            Summary:
                                                                                                                                                                                                                            Get latest Market Research Reports on Arrhythmias. Industry analysis & Market Report on Arrhythmias is a syndicated market report, published as Arrhythmias - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Arrhythmias market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                                                                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                                                                            Purchase this Report

                                                                                                                                                                                                                            $2,000.00
                                                                                                                                                                                                                            $4,000.00
                                                                                                                                                                                                                            $6,000.00
                                                                                                                                                                                                                            1,343.00
                                                                                                                                                                                                                            2,686.00
                                                                                                                                                                                                                            4,029.00
                                                                                                                                                                                                                            1,840.40
                                                                                                                                                                                                                            3,680.80
                                                                                                                                                                                                                            5,521.20
                                                                                                                                                                                                                            242,280.00
                                                                                                                                                                                                                            484,560.00
                                                                                                                                                                                                                            726,840.00
                                                                                                                                                                                                                            132,626.80
                                                                                                                                                                                                                            265,253.60
                                                                                                                                                                                                                            397,880.40
                                                                                                                                                                                                                            Add To Cart Credit card Logo

                                                                                                                                                                                                                            Related Reports


                                                                                                                                                                                                                            Reason to Buy

                                                                                                                                                                                                                            Request for Sample of this report